LDL-C TARGET ACHIEVEMENT AFTER ADDING EVINACUMAB IN A PATIENT WITH A RARE HOMOZYGOUS AUTOSOMAL RECESSIVE HYPERCHOLESTEROLEMIA
Anno:
2025
Homozygous Autosomal Recessive Hypercholesterolemia (ARH) is a rare form of genetic hypercholesterolemia caused by mutations in low density lipoprotein receptor adaptor protein 1(LDLRAP1)characterized by very high levels of low-density-lipoprotein-cholesterol (LDL-C),leading to aggressive and premature atherosclerotic cardiovascular disease.The gold standard treatment is LDL-apheresis.Novel therapies are thus needed for this severe…